In the past week, CMRX stock has gone up by 15.23%, with a monthly gain of 295.45% and a quarterly surge of 291.10%. The volatility ratio for the week is 9.59%, and the volatility levels for the last 30 days are 12.64% for Chimerix Inc The simple moving average for the past 20 days is 38.79% for CMRX’s stock, with a 221.96% simple moving average for the past 200 days.
Is It Worth Investing in Chimerix Inc (NASDAQ: CMRX) Right Now?
The 36-month beta value for CMRX is also noteworthy at 0.44. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CMRX is 80.14M, and at present, short sellers hold a 4.29% of that float. The average trading volume of CMRX on January 01, 2025 was 3.93M shares.
CMRX) stock’s latest price update
Chimerix Inc (NASDAQ: CMRX) has seen a rise in its stock price by 1.16 in relation to its previous close of 3.44. However, the company has experienced a 15.23% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-12-30 that Secures Access of Up To $30 Million to Support Potential Launch Through Silicon Valley Bank Credit Facility Secures Access of Up To $30 Million to Support Potential Launch Through Silicon Valley Bank Credit Facility
Analysts’ Opinion of CMRX
Many brokerage firms have already submitted their reports for CMRX stocks, with Robert W. Baird repeating the rating for CMRX by listing it as a “Outperform.” The predicted price for CMRX in the upcoming period, according to Robert W. Baird is $7 based on the research report published on May 23, 2023 of the previous year 2023.
CapitalOne, on the other hand, stated in their research note that they expect to see CMRX reach a price target of $7. The rating they have provided for CMRX stocks is “Overweight” according to the report published on September 07th, 2022.
Maxim Group gave a rating of “Buy” to CMRX, setting the target price at $20 in the report published on April 29th of the previous year.
CMRX Trading at 123.46% from the 50-Day Moving Average
After a stumble in the market that brought CMRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.05% of loss for the given period.
Volatility was left at 12.64%, however, over the last 30 days, the volatility rate increased by 9.59%, as shares surge +291.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +295.01% upper at present.
During the last 5 trading sessions, CMRX rose by +15.23%, which changed the moving average for the period of 200-days by +202.61% in comparison to the 20-day moving average, which settled at $2.51. In addition, Chimerix Inc saw 261.56% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CMRX starting from Michael Andriole, who proposed sale 1,500 shares at the price of $0.87 back on Aug 08 ’24. After this action, Michael Andriole now owns shares of Chimerix Inc, valued at $1,300 using the latest closing price.
Andriole Michael T., the PRESIDENT AND CEO of Chimerix Inc, sale 1,285 shares at $0.83 during a trade that took place back on Aug 08 ’24, which means that Andriole Michael T. is holding 462,453 shares at $1,065 based on the most recent closing price.
Stock Fundamentals for CMRX
Current profitability levels for the company are sitting at:
- -583.81 for the present operating margin
- -132.86 for the gross margin
The net margin for Chimerix Inc stands at -525.75. The total capital return value is set at -0.68. Equity return is now at value -48.59, with -43.54 for asset returns.
Currently, EBITDA for the company is -92.97 million with net debt to EBITDA at 0.25. When we switch over and look at the enterprise to sales, we see a ratio of 1823.75. The receivables turnover for the company is 1.03for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.33.
Conclusion
In summary, Chimerix Inc (CMRX) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
